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Abstract
Synchrotron microbeam radiation therapy (MRT) is an advanced form of 
radiotherapy for which it is extremely difficult to provide adequate quality 
assurance. This may delay or limit its clinical uptake, particularly in the 
paediatric patient populations for whom it could be especially suitable. This 
study investigates the extent to which new developments in 3D dosimetry using 
optical computed tomography (CT) can visualise MRT dose distributions, and 
assesses what further developments are necessary before fully quantitative 3D 
measurements can be achieved.
Two experiments are reported. In the first cylindrical samples of the 
radiochromic polymer PRESAGE® were irradiated with different complex 
MRT geometries including multiport treatments of collimated ‘pencil’ 
beams, interlaced microplanar arrays and a multiport treatment using an 
anthropomorphic head phantom. Samples were scanned using transmission 
optical CT. In the second experiment, optical CT measurements of the 
biologically important peak-to-valley dose ratio (PVDR) were compared with 
expected values from Monte Carlo simulations. The depth-of-field (DOF) 
of the optical CT system was characterised using a knife-edge method and 
the possibility of spatial resolution improvement through deconvolution of a 
measured point spread function (PSF) was investigated.
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3D datasets from the first experiment revealed excellent visualisation 
of the 50 μm beams and various discrepancies from the planned delivery 
dose were found. The optical CT PVDR measurements were found to be 
consistently 30% of the expected Monte Carlo values and deconvolution of 
the microbeam profiles was found to lead to increased noise. The reason for 
the underestimation of the PVDR by optical CT was attributed to lack of 
spatial resolution, supported by the results of the DOF characterisation.
Solutions are suggested for the outstanding challenges and the data are 
shown already to be useful in identifying potential treatment anomalies.
Keywords: optical CT, x-ray microbeam therapy, 3D dosimetry, PRESAGE®
S  Online supplementary data available from stacks.iop.org/PMB/61/320/
mmedia
(Some figures may appear in colour only in the online journal)
1. Introduction
Synchrotron microbeam radiation therapy (MRT) is an advanced form of external beam radio-
therapy treatment. It exploits the remarkable tolerance healthy tissue has for high doses of 
radiation when the doses are ‘spatially fractionated’, that is, confined to a set of spatially 
separated regions each of very small volume. The effects of such radiation are strongly depen-
dent on the geometry of the regions exposed and, in particular, on the width of the incident 
beam of radiation (Bräuer-Krisch et al 2010a). It is hypothesised that, although normal tis-
sue in the beam path is destroyed, regeneration of blood vessels across the ablated region is 
possible providing the beam width is sufficiently small and the ‘valley dose’ sufficiently low. 
By contrast, tumour microvasculature seems less able to repair the damage caused. Although 
the molecular mechanisms of this selective radiovulnerability remain under investigation, the 
clinical potential of microbeam therapy is clear (Crosbie et al 2010) and there are early indica-
tions that such methods may also be useful in the treatment of other, non-cancerous diseases 
(Pouyatos et al 2013).
Despite the many advantages of MRT and our increasing ability to administer it safely, it is 
still extremely difficult to verify that the planned dose distribution has been accurately deliv-
ered. This uncertainty complicates the interpretation of biological outcomes and may delay or 
limit its clinical uptake, particularly in the paediatric patient populations for whom it could be 
especially suitable (Laissue et al 2001).
There are two competing measurement problems in modern MRT, which make it extremely 
challenging to devise a single technique for treatment verification and quality assurance (QA). 
Firstly, there is the need to characterise the individual microbeams and make accurate meas-
urements of the peak-to-valley dose ratio (PVDR). The small width of the microbeams, typi-
cally 50–100 μm, means that traditional radiotherapy measurement devices (ion chambers, 
diode arrays, etc.) are inadequate. An ideal dosimeter for MRT would have micron-scale spa-
tial resolution with a dynamic range of the order of 10 000. As described by (Bräuer-Krisch 
et al 2010b), there is a long history of investigating different techniques to obtain accurate 
dosimetry in this challenging situation. The devices evaluated include metal oxide-semicon-
ductor field-effect transistors (MOSFETs) (Bräuer-Krisch et al 2003, Siegbahn et al 2009), 
fluorescent nuclear track detectors (Akselrod et al 2006) and silicon strip detectors (Lerch 
et al 2011). The second problem is that, as MRT becomes increasingly sophisticated, there 
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will be a need to provide high-quality 3D dosimetry over the entire treated volume. It is this 
requirement that we address in the current work.
Already, experimental MRT treatments are making use of dose distributions of consid-
erable sophistication, most recently involving interlaced microbeams (Serduc et al 2009, 
Serduc et al 2010, Bräuer-Krisch et al 2013), and the introduction of conformality would be a 
plausible next step. Moving forward, some of the 3D treatment verification problems already 
encountered in conventional radiotherapy on standard linacs may need to be re-examined in 
the MRT context. The widely adopted solutions in the clinic (transit dosimetry using portal 
imaging or dose verification in phantoms via ion chamber or diode arrays) are not available 
for MRT because of the size of the microbeams.
Previous studies have used thermoluminescent dosimeter (TLD) (Ptaszkiewicz et al 2008) 
and radiochromic film (e.g. (Crosbie et al 2008, Serduc et al 2010)) dosimetry to obtain 2D 
information. Quantitative comparisons of film dosimetry and Monte Carlo models have shown 
good agreement, typically between 2 and 15% depending on the exact measurement location 
(Martinez-Rovira et al 2012). However, whilst film is suitable for some applications (and 
particularly for the QA of individual fields), 2D information is of limited use in complex 3D 
treatments, such as those presented here. This argument also applies to the direct biological 
verification of treatment via histological sectioning. Although such work is indispensible for 
understanding the radiobiological effect of MRT (Crosbie et al 2010), the quantity of data 
obtained and spatial coverage are often much more limited. Thus, it is of great interest to 
develop fully 3D methods of quantitative, high-resolution dosimetry.
Full 3D dosimetry of radiosensitive samples has a long history. At the outset, the predomi-
nant readout modality was Magnetic Resonance Imaging (MRI) of radiochromic Fricke gels 
(Appleby et al 1987, Schreiner 2004) or polymer gels (Maryanski et al 1993, Baldock et al 
2010). The application of MRI dosimetry to MRT was investigated by (Dilmanian et al 2008) 
but only for ‘thick microbeams’ (680 μm) using a commercial scanner. (Berg et al 2004), 
(Bayreder et al 2008) and (Heilemann et al 2015) have investigated the limits of MRI gel 
dosimetry for resolving small features, but the minimum width of irradiated region was 200 μm, 
a factor of four larger than the width of the microplanar beams studied here. The primary 
limitations for the MRI method are the r−3 dependence of image signal-to-noise ratio (SNR) 
and the diffusion path length of water molecules during each scan step. A further problem is 
that the gels used cannot always support the high dose rates encountered in synchrotron MRT.
Optical computed tomography (CT) (Gore et al 1996, Doran 2009) is an alternative modal-
ity for 3D dosimetry readout. Used for some time as a method of clinical verification in large 
dosimeters, the potential for optical CT using the radiochromic plastic PRESAGE® dosimeter 
in small-field imaging of millimetre-sized beams is now a subject of considerable interest 
(Corey et al 2010). Optical CT microscopy, also known as optical projection tomography 
(OPT), was first demonstrated in this context by (Doran et al 2010) and is an emerging modal-
ity that could fulfil the requirements for MRT dosimetry. It offers the exciting possibility of 
quantitative 3D data with microscopic resolution, but over an extended field-of-view (FOV) 
within a macroscopic object. A recent study (Doran et al 2013) performed a baseline assess-
ment of the dosimetric accuracy of a microscopy system but highlighted that further improve-
ments in resolution were necessary. To date, the highest nominal spatial resolution so far 
reported with PRESAGE® is 78 nm, but those results were obtained using traditional fluores-
cent microscopy (Annabell et al 2012) rather than transmission optical CT as here and, so far, 
only for 1D patterns of dose deposition. It is not yet clear whether that technique will scale up 
to 3D over an extended field-of-view.
In this article, we demonstrate the current capabilities and limitations of the optical CT sys-
tem for the quantitative measurement of microbeams, and we present 3D images of a range of 
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complex MRT treatments. Given the prior experience of MRI described above, it was uncer-
tain at the outset of our research whether such a 3D imaging technique would have sufficient 
resolution to image the microbeams at all, and obtaining truly quantitative data was an aspi-
ration. However, as described below, the visualisation results were shown to be immediately 
useful in revealing discrepancies that might be attributable to mechanical issues during the 
dose delivery and the 3D data show considerable potential for future developments of the 
method. Previous reports have shown a decrease in contrast when imaging small features with 
optical CT in what was thought to be a modulation transfer function (MTF)-related effect 
(Doran et al 2013b). This raised the question of whether quantitative measurements of the 
microbeams themselves were possible with optical CT.
The current work thus has two aims. Section  2: 3D Visualisation establishes how 
PRESAGE® and optical CT can be used as a QA tool for MRT, fulfilling the 3D dosimetry 
information gap. Section 3: Quantitative measurements of PVDR, investigates in detail the 
reduction in contrast seen previously and assesses the extent to which optical CT can be used 
for PVDR measurement.
2. 3D Visualisation
2.1. Methods and materials
2.1.1. Samples. Custom-made PRESAGE® plastic dosimeters were supplied by the manu-
facturer (Heuris Pharma, Skillman, NJ). PRESAGE® is a solid, radiochromic 3D dosimeter 
consisting of a transparent polyurethane matrix (approximately 90% of the dosimeter by 
weight), 2% leuco malachite green, and a 4% trihalomethane initiator, with the remainder 
being a solubilizer for the dye and initiator. The PRESAGE® formulation used here has the 
stoichiometric chemical formula C304H510N20O71SBr, and a mass density of 1.11 g cm−3. The 
polyurethane leucodye solution was poured into a mould and pressurized at 60 psi for at least 
48 h to ensure a solid dosimeter. Samples were supplied in the form of cylinders of diameter 
22 mm and 9.7 mm. These were machined to a uniform heights of 50 mm for the 9.7 mm diam-
eter samples and 80 mm for the 22 mm diameter samples and inserted into a bespoke Perspex 
phantom that was used both for holding the samples and to provide adequate scatter condi-
tions for secondary electronic equilibrium (Doran et al 2013).
2.1.2. Sample irradiation. Irradiations were carried out at the European synchrotron radiation 
facility (ESRF) in Grenoble, on the ID17 biomedical beamline. The methodology, equip-
ment and beam characteristics have already been described in detail (Doran et al 2010, Abdul 
 Rahman et al 2011, Doran et al 2013) and, here, the additional information relates only to the 
specifics of the MRT irradiations delivered.
Successful delivery of MRT dose patterns is extremely demanding from an engineering 
point of view. Accurate sample alignment plays a key role and a 3D dosimeter capable of a 
simple ‘hit-or-miss’ assessment is highly desirable. The pattern formed by the 2D intersection 
of multiple, angled arrays of microbeams has the potential to be extremely complicated and 
so the use of a single or small number of 2D films for QA purposes is not a viable option. 
Furthermore, performing accurate quantitative measurements of 2D optical density on multi-
ple films is an extremely time-consuming operation. Having a method of generating informa-
tion to correct or improve the MRT delivery would be extremely useful. For this purpose, fully 
quantitative measurements of peak dose would not be required. Instead the main requirements 
are fast readout, ease of use, spatial accuracy and visualisation of dose integration.
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To test whether optical CT is suitable in this capacity, different complex MRT irradiations 
were performed, listed in table 1. These included collimated beams (pencil beams, sample 
1.1) (Bräuer-Krisch et al 2010a), interlacing of microplanar beams (multiport and offset, sam-
ple 1.2) (Serduc et al 2010), multi-port cross-firing of microplanar beams with the use of an 
anthropomorphic head phantom (sample 1.3, see figure 1) (Requardt et al 2005). All beams had 
a full width half maximum (FWHM) of 50 μm and centre-to-centre (ctc) spacing of 400 μm 
between beams.
2.1.3. Optical CT microscopy. Imaging was performed using the optical CT microscope 
described in (Doran et al 2013) with improvements to the camera, computer and positioning 
system. A new camera (Zyla sCMOS, Andor Technology PLC, Belfast, UK) with a large pixel 
array and fast frame-rate allows for much faster imaging with larger projection matrix size. 
Camera sensor technology has developed rapidly in recent years and a number of high-quality, 
affordable options are available. A new PC with 256GB RAM (Dell), controls acquisition and 
performs reconstruction, meaning that scans can be carried out much faster. With the previ-
ously reported system it took approximately 1 h 10 min to acquire the data for a 5123 voxel 
reconstructed volume. The equivalent scan takes under 3 min with the new system, making 
optical CT a viable system for in situ feedback for MRT irradiations. Although, for the results 
presented here, the scanner and irradiation facility were not co-located, there is clear poten-
tial for installing an optical CT microscope in the beamline ‘hutch’ of the accelerator. A new 
automated positioning system (LTS series, Thorlabs) and custom-made sample mounts allows 
reproducible sample scanning position, making it easy to measure the samples immediately 
pre- and post-irradiation, thus potentially allowing absolute measurements of optical density 
change in the future, reducing artefacts and baseline uncertainties.
Samples 1.1  −  1.3 were scanned using a ‘fast’ three minute scan of 1000 projections over 
180° rotation, each of 512  ×  512 pixels, satisfying the Nyquist condition for the reconstruc-
tion of an isotropic data volume of 5123 voxels. The FOV was (13.3 mm)3 for the 9.7 mm 
diameter samples (1.1 and 1.2) and (26.6 mm)3 for the 22 mm diameter sample (1.3) with 
isotropic reconstructed voxel sizes of (26 μm)3 and (52 μm)3 respectively.
2.2. Results
High quality image datasets were acquired for each sample and the microbeams are easily 
visualised. The reconstructed 3D datasets can be visualised in different ways to provide an 
assessment of the irradiation. Figure 2 shows a maximum intensity projection (MIP) image of 
a reconstructed image volume of sample 1.1, with the full dataset available in movie format as 
online supplementary material (stacks.iop.org/PMB/61/320/mmedia). This type of visualisa-
tion is very powerful, allowing the user to assess quickly that the pencil beam irradiation has 
been delivered successfully and is well centred within the sample. Confirming this would be 
very difficult using 2D dosimeters.
Figure 3 shows a reconstructed slice through sample 1.2, irradiated with an interlaced 
dose pattern. More views are available in supplementary video material (stacks.iop.org/
PMB/61/320/mmedia). It is clear that interlacing of the centre and left fields was successful. 
However, the centre and right fields are overlapping and the increased dose is visualised as a 
brighter region on optical CT images. This demonstrates the qualitative dose integration visu-
alisation power of optical CT, which would be very helpful during MRT set-up even without 
a quantitative measure of the increased dose. This visualisation could inform on patient safety 
and would be complicated to measure with a 2D dosimeter.
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Figure 4 shows two orthogonal reconstructed slices through sample 1.3 which was irradi-
ated inside an anthropomorphic head phantom with a multiport cross-firing geometry. With 
the ability to choose the image plane arbitrarily, it is easy to find a slice that gives direct 
interpretation of the delivered dose, unlike the image shown in figure 4(a). The second image, 
shown in figure 4(b), clearly shows that two of the delivered fields are off-centre and a simple 
measurement the offset could be used to correct the MRT geometry (red arrow). This inter-
pretation would be very difficult from a 2D measurement as the 2D dosimeter would need to 
be placed very accurately.
3. Quantitative measurements of PVDR
3.1. Theory
Previous publications have noted a reduction of optical CT image contrast of small features 
as the feature size approaches the resolution, resulting in an apparently different PRESAGE® 
dose response (Doran et al 2013b). This effect is evident even when the feature size is several 
times the nominal spatial resolution and was thought to be an effect of the modulation transfer 
function (MTF). Therefore, it was important to characterise the MTF of our system over an 
extended depth-of-field (DOF) before making quantitative measurements of microbeams.
Ideally the DOF of projection images should be larger than or equal to the sample size, as 
demonstrated in figure 5. However, there is a trade-off between DOF and resolution, Δx, given 

















where, nbath is the refractive index of the medium surrounding the sample, n is the refractive 
index of the medium around the lens, λ is the wavelength of light, e is the pixel size of the 
camera and Mlat is the lateral magnification of the system. The DOF of the system can be 
adjusted by adjusting the overall acceptance angle of the system, θ, which in turn controls the 
numerical aperture (NA) and this is inversely proportional to the resolution,







1.1 Pencil Beams 300 9.7 Four fields of 7  ×  7 interlaced circularly 
collimated ‘pencil’ beams, separated by 
45° rotation.
1.2 Interlacing 200 9.7 Four (5  ×  5)mm2 microplanar arrays 
separated by 45° rotation and 200 μm 
offset.
1.3 Multiport crossfiring 200 22 In anthropomorphic head phantom, 
three (10  ×  10)mm2 microplanar arrays 
 separated by 60° rotation.
2.1 Single microplanar array 100 9.7 (10  ×  10)mm2 microplanar array field.
2.2 Single microplanar 
array
50 9.7 (10  ×  10)mm2 microplanar array field.
2.3 Single microplanar 
array
100 9.7 (30  ×  30)mm2 microplanar array field.










In a basic simulation of our system, we found that to measure the peak of a Monte Carlo-
simulated 50 μm microbeam with an error of less than 1%, a sampling resolution of 10 μm 
is required. Therefore, the optimum NA giving this resolution over the largest DOF needs to 
be found.
One method of measuring the resolution of a system is to obtain the MTF, which measures 
how well the system can transmit spatial frequencies. This can be calculated by taking the 
Fourier transform of the derivative of the edge-spread function (ESF),
Figure 1. (a) PRESAGE® sample 1.3 in place in anthropomorphic head phantom and 
(b) the head phantom being positioned for irradiation at the ESRF.
Figure 2. A maximum intensity projection (MIP) image of sample 1.1 showing 
excellent visualisation of the microbeams, confirming successful irradiation which was 
well centred within the sample. Full 3D reconstruction can be seen in a video available 
online. (stacks.iop.org/PMB/61/320/mmedia)
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where the ESF can be measured using a knife-edge test object (see (Chen et al 2012) for 
details).
3.2. Methods
3.2.1. Depth of field characterisation. A series of experiments similar to those performed by 
(Chen et al 2012) was undertaken to characterise the DOF of the optical CT system for dif-
ferent NA values. The NA is controlled through an aperture in the Leica lens system of our 
optical CT microscopy scanner. The aperture can be set to five repeatable sizes, labelled A1 
(smallest NA) to A5 (largest NA).
A knife edge was positioned at the focal plane and 50 projection images of matrix size 
2048  ×  2048 were acquired and averaged to improve the SNR. The knife edge was moved in 
steps of 0.1 mm away from the focal plane in both directions along the optical axis. Images 
were acquired over a distance of 0.5 mm in each direction giving a total distance of 10 mm, the 
same as the FOV of each projection image. This was repeated for five different NA settings of 
the microscope lens, A1  −  A5.
The MTF was calculated from the ESF, measured across the centre of the knife-edge 
images, according to equation (3) for each position along the optical axis and for each NA 
value. The MTF was represented by a grey level in a 2D image in which the horizontal coordi-
nate corresponds to spatial frequency, up to the desired 100 mm−1 (equivalent to a 10 μm line-
pair), and the vertical coordinate corresponds to position along the optical axis. This allows 
visualisation of the DOF for each of the different NA values.
Figure 3. A reconstructed slice through sample 1.2 with an interlaced dose pattern 
which has overlapped, leading to overdosing compared to the expected treatment. 
Further slices from the full dataset are available in a video online. (stacks.iop.org/
PMB/61/320/mmedia)
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The maximum resolution and corresponding DOF were measured for each NA setting. The 
maximum resolution was defined as the largest spatial frequency with an MTF above 10% at 
the focal plane. The DOF for this frequency was defined as the distance along the optical axis 
for which this spatial frequency had an MTF above 10%.
3.2.2. PVDR measurement. PRESAGE® samples were irradiated with microplanar arrays of 
different field sizes and different peak doses to provide a range of PVDRs for comparison with 
Monte Carlo and film data. Samples were laid in the phantom and exposed end-on to a single 
irradiation from a multi-slit collimator of slit width 50 μm, centre-to-centre spacing 400 μm 
(Bräuer-Krisch et al 2009). Two 9.7 mm diameter samples were exposed with a nominal peak 
Figure 4. (a) A reconstructed slice through sample 1.3 which was irradiated inside an 
anthropomorphic head phantom with a multiport cross-firing geometry. From this view 
it is difficult to tell whether the irradiation was successful. (b) A reconstructed slice in 
the orthogonal plane, with the z position of (a) marked by the dotted line. Green arrows 
(10.0 mm, 11.52 mm) mark field measurements which are as expected, showing that 
three irradiations have been delivered at the expected field size and spaced 60° apart as 
expected. However, two of the fields are offset from the centre of the sample, (c) shows 
the expected shape of the irradiation. The red arrow (4.67 mm) denotes the offset of the 
two incorrect fields from the centre of the sample, this measurement could be used to 
correct the MRT geometry.
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dose to the surface of the dosimeter of 50 Gy and 100 Gy, both with a field size of (10  ×  10) 
mm2 (samples 2.1 and 2.2 respectively). A third 9.7 mm sample was exposed with a nominal 
peak dose of 100 Gy, with field size (30  ×  30) mm2 (sample 2.3, see table 1).
Samples 2.1  −  2.3 were scanned using a ‘high-resolution’ scan consisting of 3300 pro-
jections, each averaged over five acquisitions of 2048  ×  256 pixels, reconstructed to a data 
volume of 2048  ×  2048  ×  256 voxels with FOV (10  ×  10  ×  1.25) mm. Using the full matrix 
size of the new camera across the width of the sample allows significantly higher sampling 
frequency over previous reports, with an isotropic reconstructed voxel size of (5.2 μm)3. 
A smaller matrix height of 256 pixels was chosen for reduced acquisition and reconstruction 
times. The large computer RAM of 256GB allows readout of the large amounts of data simul-
taneously making these scans a manageable 1 hour long. The projections were acquired with 
the largest DOF setting (smallest NA, setting A1), reflecting the ‘ideal’ focal situation of con-
stant resolution across the entire sample. The samples were scanned at depths of 0.3 cm, 1 cm 
and 4 cm for comparison with Monte Carlo and film measurements of PVDR (Martinez-Rovira 
et al 2012).
3.2.2.1. Deconvolution. Using a high NA would give a high resolution at the cost of a small 
DOF, resulting in out-of-focus data being superimposed on top of in-focus data requiring 
deconvolution. To investigate whether the resolution could be improved through deconvolu-
tion with a measured point-spread-function (PSF), a PSF phantom was designed. The PSF 
phantom was made using 1 μm diameter beads (56314, Sigma-Aldrich) which were suspended 
in 0.75% agarose gel. The gel was dehydrated in 100% ethanol and then soaked in matching 
fluid (97% ethyl hexyl salicylate and 3% 4-methoxycinnamic acid 2-ethylhexyl ester) giving 
the same refractive index as the PRESAGE®. Superglue was used to attach the bead phantom 
to the end of PRESAGE® sample 2.1. The bead phantom was then included in the FOV during 
a ‘high-resolution’ scan consisting of 3300 projections, each averaged over five acquisitions 
of 2048  ×  256 pixels, reconstructed to a data volume of 2048  ×  2048  ×  256 voxels with FOV 
(10  ×  10  ×  1.25) mm. The lens aperture was set to A4 which had the largest DOF for 10 μm 
resolution (see table 2).
Figure 5. (a) Ideal position of depth of field and focal plane for optical CT imaging. 
(b) Reconstructed image of a gel phantom containing 1 μm beads demonstrating how 
limited depth of field in projection images affects reconstructed images.
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When images were reconstructed, in principle a bead at point (x, y, z) has experienced the 
same optical blur as at point (x, y, z  +  Δz). Assuming this, a bead in the centre of the sample 
in good focus was used as a PSF during Richardson-Lucy deconvolution of the microbeam 
profile axially above it at a depth of 0.3 cm in PRESAGE®. Deconvolution was performed 
in the IDL software environment (Exelis Visual Information Solutions, Boulder, CO) using 
the ‘deconv’ tool (Varosi et al 1993), assuming Poisson noise. The PVDR from the resulting 
deconvolved profile was calculated for different numbers of deconvolution iterations.
3.3. Results
3.3.1. Depth of field characterisation. The results of knife-edge measurements of the MTF 
over an extended DOF are shown in figure 6. These results show that with NA setting A1, the 
ideal situation of a constant resolution across the entire FOV is broadly achieved. However, 
the maximum resolution is only 21.5  ±  0.5 μm. A resolution of 10 μm is achieved when the 
NA is increased at an aperture setting of A4, but in this case, the DOF less than 0.6 mm (see 
table 2).
3.3.2. PVDR measurement. Figures 7(a) and (b) show a reconstructed optical CT image of 
PRESAGE® sample 2.1 and the associated profile through the marked position on the image. 
To reduce noise, profiles were median-averaged in the two orthogonal directions to the micro-
beam variation resulting in an effective pixel size of 104 μm in those directions and 5.2 μm 
across the profile. Over this small distance there is no divergence of the peak pixel position in 
the orthogonal directions as the beam divergence is very small.
As no part of the sample was unirradiated, the baseline corresponding to zero-dose pixel 
value used is an average of values obtained from unirradiated areas of other samples from the 
same batch, hence the large uncertainty marked on the graph. In future a pre-scan can reduce 
this error. As can be seen the sampling frequency is very high, however the beams appear 
blurred compared to the shape observed with other higher-resolution modalities.
The PVDR was calculated for sample 2.1 at depths of 0.3 cm, 1 cm and 4 cm. Samples 2.2 
and 2.3 were also measured at a depth of 4 cm. The results of the optical CT PVDR measure-
ments are plotted against the expected values from Monte Carlo simulation (Martinez-Rovira 
et al 2012) in figure  7(c), where the large error-bars on the optical CT measurements are 
principally due to the baseline uncertainty. Encouragingly, the variation of PVDR with depth 
and field size corresponds extremely well between optical CT and Monte Carlo measurements 
with a very high correlation coefficient for the linear fit. However, the absolute value of the 
PVDR, as measured by optical CT is consistently only 30% of the expected value. There could 
be several reasons for this. Given that decreasing the peak entrance dose has no effect (sample 
2.2) it is unlikely to be due to a lack of dynamic range in the optical CT scanner. Sample 2.3 
has a larger field size and therefore larger valley dose. Given that this measurement also fits 
the trend it is unlikely that low SNR in the valley measurement is the primary source of the 
error.
The full-width half-maximum (FWHM) of one of the beams in figure 7(b) is 62.4 μm, not 
50 μm as expected. This implies that the profile is blurred, which would reduce the peak value 
measured. Although the nominal pixel size is 5.2 μm, the true resolution is lower than this, 
limited by the imaging optics, as expected from our MTF measurements.
3.3.2.1. Deconvolution. Figure 8(a) shows a microbeam profile and its improved shape after 
deconvolution with a PSF measured using a 1 μm diameter bead. However, figure 8(b) clearly 
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demonstrates that although the deconvolution improves the shape of the profile, the PVDR 
measured is dependent on the number of deconvolution iterations performed, and does not 
converge before the noise reaches an unacceptable level. This means that this type of decon-
volution approach is not reliable enough to use in quantitative measurements of PVDR of 
microbeams. This may also apply to depth-of-field scanning techniques previously employed 
in biological imaging to improve the resolution (Fauver et al 2005).
Table 2. Maximum resolution and corresponding depth-of-fields for different numerical 
aperture (NA) settings on the optical CT system. The uncertainties reflect noise in the 
modulation transfer function (MTF) measurements. The NA for each aperture settting 
was calculated from information supplied by the manufacturer.
NA setting NA Resolution [μm] Depth of field [mm]
A1 0.0086 21.5  ±  0.5 9.3  ±  0.4
A2 0.0155 13.7  ±  0.1 2.4  ±  0.2
A3 0.0204 12.0  ±  0.2 1.6  ±  0.2
A4 0.0252 10.1  ±  0.2 0.6  ±  0.1
A5 0.0290 9.7  ±  0.2 0.4  ±  0.1
Figure 6. Measurements of the modulation transfer function (MTF) along the optical 
axis for different numerical aperture (NA) settings of the system, (a) A1 (b) A2 (c) A3 
(d) A4. This allows visualisation of the depth-of-field (DOF).
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Figure 7. (a) Reconstructed image of sample 2.1 and (b) the corresponding profile 
through microbeams. The baseline is an average value from unirradiated areas on other 
samples from the same batch, hence the large uncertainty. The profile was median 
averaged along 20 pixels in the directions orthogonal to the profile to improve the SNR 
resulting in 5.2 μm pixel size across the profile and 104 μm pixel size in the orthogonal 
directions. (c) Comparison of PVDR measurements using optical CT against expected 
values from Monte Carlo simulation (Martinez-Rovira et al 2012).
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4. Discussion
Section 2 clearly suggests that optical CT has the potential to play an important role in MRT 
QA. The data of figures 2–4, rendered in 3D in the accompanying movies, demonstrate graph-
ically where the real benefit of the optical CT technique lies. Image data may be acquired 
from the entirety of the sample at high resolution in a single measurement. This would be 
very useful for hit-or-miss assessment and imaging is now fast enough to provide correction 
information to improve MRT irradiations in situ. Compared with a single, or small number 
of 2D film images, there are no difficulties in interpreting the measured dose distribution in 
Figure 8. (a) A microbeam profile from sample 2.1 and the deconvolved profile after 4 
iterations of Richardson–Lucy deconvolution using a PSF calculated from a 1 μm bead. 
This shows that deconvolution of the PSF improves the shape of the profile however, 
(b) shows that the PVDR depends on the number of deconvolution iterations, which 
does not appear to converge before becoming extremely noisy. Therefore although 
deconvolution can qualitatively improve the images, we are hesitant to base any 
quantitative measurements on a deconvolved profile.
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multiport treatments. Using the solid PRESAGE® dosimeter also allows for end-to-end QA of 
the entire treatment process including CT scan, treatment planning, positioning and delivery 
which would be necessary before MRT is translated to clinical use. One potential future appli-
cation would be to combine PRESAGE® dosimetry with a patient motion simulating platform 
which can investigate whether very complex irradiations such as interlacing are possible with 
patient breathing motion.
The time between irradiation and readout was longer than desirable, during which time the 
samples were refrigerated. The potential time-evolution of the measured doses is discussed 
in (Doran et al 2013) but whilst the error introduced at this step is expected to be significant, 
the pertinent observation for the purposes of this work is that PRESAGE® exhibits negligible 
diffusion of the dose-reporting chromophore. Thus, blurring of the microbeam dose due to the 
delay is not expected to have occurred.
The apparatus is sufficiently compact that a copy could be installed in the MRT hutch at 
ID-17. A number of improvements to the imaging methodology would be possible if the appa-
ratus were located in situ at the beamline:
 • As was discussed in (Doran et al 2013), pre-scanning the dosimeter would enable effects 
of refraction to be largely eliminated and an accurate zero-dose baseline to be established, 
for absolute measurements of valley dose given the new accurate positioning system.
 • Images could be acquired within minutes of the end of the irradiation, eliminating any 
uncertainties caused by delayed readout, for example, related to time-evolution of the 
PRESAGE® dose-response (Skyt et al 2011, 2012).
 • Further improvements in image SNR and extensions to the dynamic range of acquired 
data would be achievable via the acquisition of multiple datasets with different levels of 
illumination (Krstajic and Doran 2007, Thomas et al 2011).
The results of section 3 suggest that accurate PVDR measurements are not possible with 
the current optical CT arrangement. Given the results of the knife-edge measurements of MTF 
along the optical axis, we believe the underestimation of the PVDR by optical CT is primar-
ily due to lack of true spatial resolution. Attempts to improve the resolution by increasing 
the numerical aperture and deconvolution using a measured PSF lead to unreliable and noisy 
results, making these methods unsuitable for clinical measurements of PVDR.
It remains an open question as to whether the optical CT technique will in future prove 
capable of making measurements of PVDR that are competitive with other methods such as 
those employing 2D TLD films or MOSFET detectors. There are two possible avenues to 
move forward with quantitative microbeam measurements using optical CT.
First, using a smaller sample would mean that both the necessary FOV and DOF can be 
decreased, making it possible to increase the magnification and resolution. Although this 
involves the sacrifice of spatial information across the beams, full depth information would 
still be retained. This would enable, among other things, measurement of the effects of scatter-
ing along the entire length of the microbeams, rather than simply at a single depth determined 
by the detector location.
Second, while the measured resolution of 21.5  ±  0.5 μm in projections with NA setting 
A1 is insufficient for sampling the peak dose, it should be sufficient for quantitatively meas-
uring the valley dose, which is four times wider than the peak. Arguably, in terms of patient 
safety the valley dose is the most important factor, as once the peak is over a certain value, 
cell death will occur. Therefore, having a valley measurement in 3D, in combination with an 
alternative 2D measurement of the peak dose on entry, could be of significant interest to the 
MRT community.
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5. Conclusions
3D images of geometrically sophisticated synchrotron microbeam therapy deliveries have 
been obtained. The most significant current limitation of the imaging technique as presented 
here is the available spatial resolution, which has been investigated in detail. Although the data 
presented here fall some way short of the dose quantification needed for complete verifica-
tion, the measurements and visualisations have already demonstrated their utility by detecting 
deviations from a planned treatment (figures 3 and 4(b)) and shown clear potential for quanti-
tative measurement of the biologically important valley dose.
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